Yes, I have heard about this:
Panel Recommends that FDA Approve Fampridine-SR (proposed name Amaya) for Symptomatic Treatment of MS — Found to improve walking speed for all types of MS
A U.S. Food and Drug Administration advisory committee today recommended that the agency approve marketing of Fampridine-SR (Acorda Therapeutics, with a proposed name change to Amaya) for its ability to improve walking speed in people with any type of multiple sclerosis. While the FDA is not required to follow the recommendations of its advisory committees, it usually does. The agency is expected to make a final decision about whether to approve the drug for market on or before the target date of October 22, 2009.
I have written about before, here. It’s an interesting lesson in capitalism. 4-AP/Fampridine, you see, is an avicide. Yep, airports and farmers use it to kill birds. You can get your pharmacist to compound the generic quick release stuff for about $50 a month. But now it has a fancy name, and will probably cost… Well, my guess Acorda will charge us poor sad cripples around $1,000 a month. For bird poison. Go capitalism!